Jamie Dananberg Insider Profile
11 Followers
Jamie Dananberg, CMO at Annexon Biosciences, holds 123.58K shares in Annexon Biosciences (Ticker: ANNX), holds 62.82K shares in Unity Biotechnology (Ticker: UNBX). Most recently, Jamie Dananberg Sold ― shares of Annexon Biosciences on Mar 04, 2026 for an estimated value of $31.60K.
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
-19.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Jamie Dananberg's holdings
Insider Roles
CMO
Roles that Jamie Dananberg holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jamie Dananberg
Jamie Dananberg's Trading History
Annexon Biosciences
Mar 04, 2026
CMO
Informative Sell
31.60K
$486.91K
Unity Biotechnology
Apr 03, 2023
―
Uninformative Sell
714.00
$3.52K
List of latest transactions for each holding click on a transaction to see Jamie Dananberg's performance on stock
You May Also Like
Jamie Dananberg insider profile FAQ
What is the percentage of profitable transactions made by Jamie Dananberg?
The percentage of profitable transactions made by Jamie Dananberg is 67%.
What is the average return per transaction made by Jamie Dananberg?
The average return per transaction made by Jamie Dananberg is -19.90%.
What stocks does Jamie Dananberg hold?
Jamie Dananberg holds: ANNX, UNBX stocks.
What was Jamie Dananberg’s latest transaction?
Jamie Dananberg latest transaction was an Informative Sell of $31.60K.
What was Jamie Dananberg's most profitable transaction?
Jamie Dananberg’s most profitable transaction was an Informative Sell of ANNX stock on March 4, 2026. The return on the trade was 12.80%.
What is Jamie Dananberg's role in Annexon Biosciences?
Jamie Dananberg's role in Annexon Biosciences is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.